Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Morning or evening patching for lazy eye? study seeks best timing

NCT ID NCT07294599

Symptom relief Sponsor: Yarmouk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This study tests whether patching the stronger eye in the morning (8-10 AM) or evening (5-7 PM) works better for improving vision in children with lazy eye (amblyopia). About 100 children aged 4-8 will wear an eye patch for 2-6 hours daily over 6 months. The goal is to see if timing affects how much vision improves, which could make treatment more effective and easier for families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eye-patching (occlusion therapy)
What this could lead to
If timing matters, this could help doctors prescribe patching at the most effective time of day, improving vision outcomes for children with lazy eye.
What could go wrong
This is a small, early-stage trial with only 100 children. The timing difference may have little or no effect on vision, and results may not apply to all types of amblyopia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Dec 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 8 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 4-8 years. * Unilateral amblyopia. * Amblyopic-eye BCVA decimal 0.17-0.67 (≈ 6/36-6/9). * Fellow-eye BCVA ≥ 0.80 decimal (≈ 6/7.5 or better). * Amblyopia type: refractive-dominant or strabismic/mixed. * Parent/guardian consent obtained. Exclusion Criteria: * Bilateral amblyopia. * Sensory-deprivation amblyopia (e.g., due to congenital cataract, ptosis, corneal opacity). * Ocular surgery within the past 6 months, or planned surgery during study. * Likely poor adherence (e.g., due to social, logistic, or family constraints).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amblyopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

amblyopia anisometropia strabismus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amblyopia

Contacts and locations

Locations

  • Irbid Medical Consultation Center

    Irbid, Irbid Governorate, 21163, Jordan

  • Princess Basma teaching hospital

    Irbid, Irbid Governorate, 21163, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.